Zejing Pharma (688266.SH): Submitting a Marketing Authorization Application for a Recombinant Human Thrombin Biological Product for External Use
- Post date April 27, 2022 — 21:18 Post Lock
Related Data
Watching the market: 2 shares violently pulled up and 1 share stopped in seconds-
April 27, 2022 — 11:10
Home » News » Zejing Pharma (688266.SH): Submitting a Marketing Authorization Application for a Recombinant Human Thrombin Biological Product for External Use